Compier Social Media

Home / Innovation / Compier Social Media

Monitor AE’s or PC’s reporting via Social Media Platforms

According to GVP Module VI, all the market authorization holders should regularly monitor the social media platforms and report the potential adverse events generated from different forums.

Our technology platform enables you to capture the relevant data from the uncontrolled and non-regulated platforms of the social media, digitalize and automate the process in compliance with the regulatory requirements.

Compier Social Media Monitoring

Compier’s Social Media Monitoring module enables a pharma company to automate the capture of Adverse events and Product complaints reported via social media platforms such as Twitter, Facebook, Youtube, Medschat with its inbuilt API.

It allows user to capture detailed information about the post and the associated followup information with prebuilt workflows. Prebuilt integration with safety system helps you completely streamline the intake process. Inbuilt KPI based dashboards offer a better insight and compliance on the complete process.

Key Product Features

PV Literature Screening
  • Captures the posts and comments from different official and non-official pages of social media platforms.
  • Captures Adverse Events or Product complaints and transmits the valid AE or PC to the integrated systems.
  • Coherent integration with the safety database (Oracle Argus or ArisG) or Product Quality Complaint Systems for further process.
  • Digitalize the existing spreadsheets with quality and compliance driven system
  • System generated alerts and notifications to meet the timelines for transmitting and processing the records
  • Product specific view of the trending platform for reporting AE’s or PC’s which helps MAH to focus more on monitoring the platform.

How Do we Deliver

Compier Social Media Monitoring is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

New Insights

Enabling eSource in Clinical Studies to Optimize Trial Quality

Source data is all information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. Electronic data source or eSource is the data that is initially recorded in electronic format in this process. Biopharma and MedTech [...]

Implementing Electronic Consent for Clinical Trial Participation

Industry Background of eConsent In an attempt to address health authority concerns and improve patient confidence, companies and independent industry bodies have experimented with electronic consent (eConsent) using electronic media such as smartphones, laptops, and tablets. Despite positive outcomes, its implementation remained experimental until FDA officially released a guidance in December 2016. Following in FDA’s [...]

Top 4 Trial Design Best Practices for Medical Device Clinical Studies

What drives the growing complexity in medical device clinical trials? The medical devices industry has revolutionized medicine with significant advances in both detection and treatment of diseases. Clinical trials for medical device regulatory approval are designed to produce valid scientific evidence of safety and effectiveness for the intended uses. Moreover, sponsors must consider designing trials [...]

Get in Touch with Us